China Universal Asset Management »

Terns Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $78k 12k 6.56
2023-12-31 $46k 7.1k 6.44
2023-09-30 $8.0k 1.6k 5.13
2023-06-30 $7.0k 743 9.42
2023-03-31 $8.0k 671 11.92
2022-12-31 $4.0k 383 10.44
2022-09-30 $2.0k 353 5.67

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Terns Pharmaceuticals

OrbiMed Advisors
Vivo Capital
VR Adviser
Braidwell
Franklin Resources
Vanguard Group
Fairmount Funds Management
Millennium Management
Henderson Group
Dr. Jeffrey R. Jay, M.D.
Perceptive Advisors
Decheng Capital
Russell Investments
Norges Bank Investment Management
Schonfeld Strategic Advisors

View all funds holding Terns Pharmaceuticals